SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-23-013599
Filing Date
2023-04-27
Accepted
2023-04-27 16:28:33
Documents
21
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A prtk-20221231.htm   iXBRL 10-K/A 500205
2 EX-31.3 prtk-12312022xexx313ceo.htm EX-31.3 5054
3 EX-31.4 prtk-12312022xexx314cfo.htm EX-31.4 5078
7 prtk-20221231_g1.jpg GRAPHIC 58286
8 prtk-20221231_g2.jpg GRAPHIC 8500
9 prtk-20221231_g3.jpg GRAPHIC 10491
10 prtk-20221231_g4.jpg GRAPHIC 9090
11 prtk-20221231_g5.jpg GRAPHIC 9474
12 prtk-20221231_g6.jpg GRAPHIC 10150
13 prtk-20221231_g7.jpg GRAPHIC 12262
  Complete submission text file 0001628280-23-013599.txt   1007757

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prtk-20221231.xsd EX-101.SCH 1983
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prtk-20221231_lab.xml EX-101.LAB 38750
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prtk-20221231_pre.xml EX-101.PRE 20698
15 EXTRACTED XBRL INSTANCE DOCUMENT prtk-20221231_htm.xml XML 18629
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36066 | Film No.: 23857484
SIC: 2834 Pharmaceutical Preparations